Phoenix Biologics Vitacarte Bovine Tracheal Cartilage has been discontinued. BioCartilage is the new replacement.
Resulting from interest in published studies using Catrix, Bio-Cartilage is a purified bovine cartilage powder developed for the nutritional supplement marketplace. Pure bovine cartilage has been clinically demonstrated to produce anti-inflammatory, anti-angiogenic and anti-mitotic activities.
Studied in clinical trials for over 20 years, Bio-Cartilage is also backed by more than 30 years of laboratory research conducted by the Lescarden research team. Their findings are regarded as the foundation for any cartilage investigation, and are universally cited by researchers and manufacturers in discussing product efficacy.
Bio-Cartilage is 100% pure bovine tracheal cartilage material, containing 50% type two collagen and 45% mucopolysaccharides, including chondroitin sulfates. Bio-Cartilage is produced to FDA Good Manufacturing Practices (GMPs) ensuring product quality and consistency. Produced for the nutritional supplement market, Bio-Cartilage is sold on a no-claims made basis.
Bio-Cartilage Applications:
Inflammatory Joint Disease
Through the natural aging process, the joints lose the ability to naturally produce chondroitin, which feeds and lubricates joints, and glucosamine, which helps to keep the cartilage healthy. Bio-Cartilage is a natural source of both of these substances. Research undertaken by Lescarden has shown very positive results in the treatment of inflammatory joint disease in animals as well as rheumatoid arthritis in humans.
Immune System Enhancer
Research indicates that bovine cartilage powder acts as a biological response modifier, regulating the activity of important components of the immune system.
People suffering from some skin disorders have also found that Bio-Cartilage can help to alleviate many of the symptoms of psoriasis. This efficacy has been proven in successful trials by Lescarden.
Cancer
The use of Bio-Cartilage to treat cancer evolved from the success of the Lescarden team in treating psoriasis. Like psoriasis, cancer is characterized by the overproliferation of cells, which form cancerous tumors. Studies have identified in Bio-Cartilage a clear protein (not collagen) that is a potent inhibitor of the growth of tumors.
Cartilage, unlike bone, has no blood vessels. Without a blood supply, many researchers believe that cartilage has an anti-angiogenic effect (inhibits blood vessel development), a process upon which the growth of solid tumors depends.
BioCartilage is distributed by CioCar Lab Ltd, a division of Lescarden Inc. Lescarden is a heavily research-oriented company that has spent more than $12 million on basic and clinical research work, safety studies and quality control. Lescarden has received an FDA Investigational New Drug Application and is now conducting multi-center clinical trials toward the eventual marketing of material as a prescription item. BioCartilage is non-toxic: extensive acute and chronic toxicity stuides have been conducted. Moreover, given the universal public health conerns of regulatory authorities for the presence pf bovine spongiform encephalitis in cattle herds, in many parts of the world, and its unknown effects upon human consumers, BioCartilage is harvested only from cattle raised in the few countries which are certified free of this disease. Public health concerns arise from the fact that bovine spongiform encephalitis had its origin of sheep, but it successfully transmuted to cattle giving rise to the suspicion has an almost inevitable lethal effect. BioCartilage is certified a being produced from cattle free of BSE.
| 
